M&A Deal Summary

CareDx Acquires Allenex AB

On April 14, 2016, CareDx acquired life science company Allenex AB

Acquisition Highlights
  • This is CareDx’s 2nd transaction in the Life Science sector.
  • This is CareDx’s 1st transaction in Sweden.

M&A Deal Summary

Date 2016-04-14
Target Allenex AB
Sector Life Science
Buyer(s) CareDx
Deal Type Add-on Acquisition

Target

Allenex AB

Stockholm, Sweden
Allenex AB is a life science company that develops, manufactures, markets and sells products for safer transplants of organs and bone marrow on the global market.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CareDx

South San Francisco, California, United States

Category Company
Founded 1998
Sector Life Science
Employees644
Revenue 334M USD (2024)
DESCRIPTION

CareDx is a molecular diagnostics company that applies modern genomics technologies to the development of molecular diagnostic assays that translate a patient's immune status into clinically actionable information. CareDx was founded in 1998 and is based in South San Francisco, California.


DEAL STATS #
Overall 2 of 8
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 7
Country: Sweden M&A 1 of 1
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-11 ImmuMetrix

Palo Alto, California, United States

ImmuMetrix is a privately held Palo Alto, California based development-stage transplant diagnostics company founded by Stephen Quake, D.Phil., with R&D programs and intellectual property in cell-free DNA.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-24 Illumina - SBT Resolver

San Diego, California, United States

Illumina, Inc. - SBT Resolver is a software for high resolution HLA typing.

Buy -